ML21287A016

From kanterella
Revision as of 14:32, 18 January 2022 by StriderTol (talk | contribs) (StriderTol Bot change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Shine Technologies, LLC, Operating License Application Supplement No. 9 Submittal of a Revision to the Shine Physical Security Plan
ML21287A016
Person / Time
Site: SHINE Medical Technologies
Issue date: 10/12/2021
From: Jim Costedio
SHINE Health. Illuminated, SHINE Technologies
To:
Document Control Desk, Office of Nuclear Reactor Regulation
References
2021-SMT-0144
Download: ML21287A016 (2)


Text

SAFEGUARDS INFORMATION IIII 111 ISH IN Health. Illuminated.

E.

October 12, 2021 2021-SMT-0144 10 CFR 50.30 10 CFR 73.67 U.S. Nuclear Regulatory Commission ATTN: Documen t Control Desk Washington, DC 20555

References:

(1) SHINE Medical Technologies, LLC letter to the NRC, "SHINE Medical Technologies, LLC Application for an Operating License," dated July 17, 2019 (ML19211C143)

(2) SHINE Medical Technologies, LLC letter to the NRC, "SHINE Medical Technologies, LLC Submittal of the SHINE Physical Security Plan," dated July 17, 2019 (ML19200A030)

SHINE Technologies, LLC Operating License Application Supplement No. 9 Submittal of a Revision to the SHINE Physical Security Plan Pursuant to 10 CFR Part 50.30, SHINE Technologies, LLC (SHINE) submitted an application for an operating license for a medical isotope production facility (Reference 1) to be located in Janesville, WI. As part of the application, and under separate cover, SHINE submitted the Physical Security Plan (Reference 2). SHINE has determined that a revision to the Physical Security Plan is necessary to address considerations discussed with the NRC Staff during a Septemb er 2021, clarification call. provides a revision the SHINE Physical Security Plan. Enclosure 1 contains safeguards information, as defined in 10 CFR 73.2. SHINE requests that the NRC withhold from unauthorized disclosure under 10 CFR 73.21.

If you liave any questions, please contact Mr. Jeff Bartelme, Director of Licensing, at 608/210-1735.

WHEN SEPARATED FROM THE ENCLOSED SAFEGUARDS INFORMATION, THIS LETTER IS UNCONTROLLED.

3400 Innovation Ct.* Janesville, WI 53546

  • 877.512.6554
  • info@shinemed.com
  • www.SHINEtechnologies.com SAFEGUARDS INFORMATION

SAFEGUARDS INFORMATION Document Control Desk Page 2 I declare under the penalty of perjury that the foregoing is true and correct.

Executed on October 12, 2021.

Very truly yours,

)Pm ~

Vice President of Regulatory Affairs and Quality SHINE Technologies, LLC Docket No. 50-608 Enclosure WHEN SEPARATED FROM THE ENCLOSED SAFEGUARDS INFORMATION, THIS LETTER IS UNCONTROLLED.

SAFEGUARDS INFORMATION